Robohub.org
 

José Alain Sahel, MD: Pathway Toward Vision Restoration, Artificial Vision, Artificial Retina, Optogenetics | CMU RI Seminar

by
11 February 2017



share this:

Link to video on YouTube

Abstract: “Progress in ophthalmology over the past decade moved preclinical data to clinical proof-of-concept studies bringing innovative therapeutic strategies to the market. Diseases such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD) destroy photoreceptors but leave intact and functional a significant number of inner retinal cells. Retinal prostheses have demonstrated ability to reactivate the remaining retinal circuits at the level of bipolar or ganglion cells, after the photoreceptor loss. Recent clinical trials have demonstrated partial restoration of vision in blind people by epiretinal (Second Sight Medical Products, Pixium Vision) and subretinal (Retina Implant AG) implants, in clinical trials and practice now. Despite a limited number of electrodes, some patients were even able to read words and recognize high-contrast objects. Currently, researchers at the Stanford University and Pixium Vision in collaboration with Institut de la Vision develop a wirelessly powered photovoltaic prosthesis in which each pixel of the subretinal array directly converts patterned pulsed near-infrared light projected from video goggles into local electric current to stimulate the nearby retinal neurons. A new asynchronous dynamic visual sensor whose function mimics photoreceptor and retinal cell responses is also under development. Optogenetics (currently under preclinical evaluation in primates) and cell therapy (ongoing first safety and tolerability clinical trials with hESC- and iPSCs-derived RPE) provide alternative approaches for vision restoration in patients with advanced stages of retinal degeneration. Combination of different therapeutic strategies may offer enhanced therapeutic effectiveness and more efficient ways to save vision. These new therapeutic tools call for identification of appropriate patient selection criteria and methods to evaluate treatments’ efficiency and assess the real benefit experienced by the patients.”




John Payne





Related posts :



50 women in robotics you need to know about 2023

Celebrating International Women in Robotics Day October 4th.
04 October 2023, by and

World Robotics 2023 report: Asia ahead of Europe and the Americas

The new World Robotics report recorded 553,052 industrial robot installations in factories around the world – a growth rate of 5% in 2022, year-on-year. By region, 73% of all newly deployed robots were installed in Asia, 15% in Europe and 10% in the Americas.

#IROS2023: A glimpse into the next generation of robotics

The 2023 EEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2023) kicks off today at the Huntington Place in Detroit, Michigan.
01 October 2023, by

Robot Talk Episode 55 – Sara Adela Abad Guaman

In the first episode of the new season, Claire chatted to Dr. Sara Adela Abad Guaman from University College London about adaptable robots inspired by nature.
30 September 2023, by

A short guide to Multidisciplinary Research

How and Why would I consider colliding two opposite disciplines in my research.
27 September 2023, by

Robo-Insight #5

In this fifth edition, we are excited to feature robot progress in human-robot interaction, agile movement, enhanced training methods, soft robotics, brain surgery, medical navigation, and ecological research. 
25 September 2023, by





©2021 - ROBOTS Association


 












©2021 - ROBOTS Association